Clinical Education Alliance (CEA) announced the appointment of Andrew Chamlin as its new Chief Commercial Officer. Chamlin joins the company during a critical period as CEA works to strengthen its position as a trusted partner for life sciences organizations by turning complex scientific discoveries into practical outcomes that improve patient care. In his role, Chamlin will lead the commercial strategy, focusing on client development and aligning CEA’s Education, Insights, and Communications teams to work toward a common goal. His priorities include accelerating company growth, deepening client relationships, and expanding CEA’s influence in translating scientific knowledge into actionable healthcare solutions.
Health Technology Insights: Prolink Names Vanessa Janus Chief Workforce Solutions Officer
Leo Tarkovsky, CEO of CEA, praised Chamlin’s leadership and experience. Tarkovsky noted their previous collaboration and emphasized Chamlin’s ability to bring clarity and drive results by simplifying complex challenges and inspiring teams. Tarkovsky expressed confidence that Chamlin’s leadership would play a key role in advancing CEA’s commercial capabilities and preparing the company for future opportunities.
Health Technology Insights: Brightwood Capital Provides Financing to Support Motor City Dental Partners’ Growth
Andrew Chamlin’s career spans leadership positions in global pharmaceutical companies, digital health firms, and major marketing agencies. Prior to joining CEA, he served as Chief Marketing Officer at Aspargo Labs, where he oversaw global commercialization and digital engagement strategies. He also held the role of Global Chief Marketing Officer at IPG Health, managing business development and marketing across a network of over 45 agencies, including McCann Health and FCB Health. Earlier in his career, Chamlin held senior leadership roles at Pfizer, Johnson & Johnson, Ironwood Pharmaceuticals, as well as at Revolution Health and WebMD’s Medscape. His experience includes driving digital transformation and improving engagement throughout the healthcare industry.
Chamlin said he is excited to join CEA at this important stage of growth. He highlighted the company’s unique position at the crossroads of science, data, and education. Chamlin plans to guide CEA’s next phase by integrating commercial strategy with innovation, including AI-powered solutions, to better meet client needs. He believes this approach will help drive meaningful change for partners, healthcare professionals, and ultimately patients worldwide.
Chamlin’s appointment reflects CEA’s ongoing commitment to innovation, integration, and expansion as the organization adapts to the evolving needs of life sciences companies and healthcare professionals around the globe.
Health Technology Insights: LucyRx Acquires CerpassRx to Expand Prescription Care
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
